Bank of America’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,242,300
| Closed | -$288M | – | 7281 |
|
|
2025
Q3 | $288M | Buy |
1,242,300
+778,500
| +168% | +$159M | 0.02% | 650 |
|
|
2025
Q2 | $86.1M | Sell |
463,800
-89,100
| -16% | -$16.6M | 0.01% | 1260 |
|
|
2025
Q1 | $116M | Sell |
552,900
-118,400
| -18% | -$23M | 0.01% | 1001 |
|
|
2024
Q4 | $119M | Sell |
671,300
-41,200
| -6% | -$7.57M | 0.01% | 929 |
|
|
2024
Q3 | $141M | Buy |
712,500
+300,500
| +73% | +$56.1M | 0.01% | 903 |
|
|
2024
Q2 | $70.7M | Sell |
412,000
-325,800
| -44% | -$54M | 0.01% | 1225 |
|
|
2024
Q1 | $134M | Sell |
737,800
-136,600
| -16% | -$23.5M | 0.01% | 865 |
|
|
2023
Q4 | $136M | Buy |
874,400
+430,600
| +97% | +$62.8M | 0.01% | 787 |
|
|
2023
Q3 | $66.2M | Sell |
443,800
-314,800
| -41% | -$46.2M | 0.01% | 1110 |
|
|
2023
Q2 | $102M | Sell |
758,600
-507,200
| -40% | -$74.4M | 0.01% | 888 |
|
|
2023
Q1 | $202M | Buy |
1,265,800
+598,900
| +90% | +$91.6M | 0.02% | 627 |
|
|
2022
Q4 | $108M | Buy |
666,900
+224,100
| +51% | +$34.4M | 0.01% | 853 |
|
|
2022
Q3 | $59.4M | Sell |
442,800
-59,800
| -12% | -$8.58M | 0.01% | 1144 |
|
|
2022
Q2 | $77M | Sell |
502,600
-38,200
| -7% | -$5.84M | 0.01% | 1020 |
|
|
2022
Q1 | $87.7M | Sell |
540,800
-211,700
| -28% | -$30.8M | 0.01% | 1023 |
|
|
2021
Q4 | $102M | Buy |
752,500
+434,800
| +137% | +$51.4M | 0.01% | 984 |
|
|
2021
Q3 | $34.3M | Sell |
317,700
-317,400
| -50% | -$36.3M | ﹤0.01% | 1637 |
|
|
2021
Q2 | $71.5M | Buy |
635,100
+273,000
| +75% | +$30.7M | 0.01% | 1129 |
|
|
2021
Q1 | $39.2M | Buy |
362,100
+198,300
| +121% | +$21.2M | ﹤0.01% | 1477 |
|
|
2020
Q4 | $17.6M | Buy |
163,800
+67,700
| +70% | +$6.51M | ﹤0.01% | 2011 |
|
|
2020
Q3 | $8.42M | Sell |
96,100
-96,200
| -50% | -$9.06M | ﹤0.01% | 2421 |
|
|
2020
Q2 | $18.9M | Sell |
192,300
-47,800
| -20% | -$4.21M | ﹤0.01% | 1656 |
|
|
2020
Q1 | $18.3M | Sell |
240,100
-189,200
| -44% | -$16.1M | ﹤0.01% | 1580 |
|
|
2019
Q4 | $38M | Buy |
429,300
+46,000
| +12% | +$3.82M | 0.01% | 1368 |
|
|
2019
Q3 | $29M | Sell |
383,300
-66,800
| -15% | -$4.58M | ﹤0.01% | 1514 |
|
|
2019
Q2 | $32.7M | Buy |
450,100
+210,000
| +87% | +$16.5M | 0.01% | 1431 |
|
|
2019
Q1 | $19.4M | Sell |
240,100
-46,500
| -16% | -$3.8M | ﹤0.01% | 1855 |
|
|
2018
Q4 | $26.4M | Buy |
286,600
+205,200
| +252% | +$18M | ﹤0.01% | 1465 |
|
|
2018
Q3 | $7.7M | Sell |
81,400
-144,300
| -64% | -$13.7M | ﹤0.01% | 2756 |
|
|
2018
Q2 | $20.9M | Buy |
225,700
+59,900
| +36% | +$5.85M | ﹤0.01% | 1776 |
|
|
2018
Q1 | $15.7M | Sell |
165,800
-122,400
| -42% | -$13.4M | ﹤0.01% | 2003 |
|
|
2017
Q4 | $27.9M | Sell |
288,200
-118,800
| -29% | -$11.2M | ﹤0.01% | 1532 |
|
|
2017
Q3 | $36.2M | Sell |
407,000
-42,800
| -10% | -$3.26M | 0.01% | 1402 |
|
|
2017
Q2 | $32.6M | Buy |
449,800
+198,200
| +79% | +$13.3M | 0.01% | 1329 |
|
|
2017
Q1 | $16.4M | Sell |
251,600
-132,500
| -34% | -$8.33M | ﹤0.01% | 1931 |
|
|
2016
Q4 | $24.1M | Buy |
384,100
+43,500
| +13% | +$2.66M | 0.01% | 1525 |
|
|
2016
Q3 | $21.5M | Sell |
340,600
-1,450,200
| -81% | -$93.9M | ﹤0.01% | 1582 |
|
|
2016
Q2 | $111M | Buy |
1,790,800
+1,616,500
| +927% | +$98.5M | 0.03% | 577 |
|
|
2016
Q1 | $9.96M | Sell |
174,300
-364,600
| -68% | -$20.3M | ﹤0.01% | 2146 |
|
|
2015
Q4 | $31.9M | Sell |
538,900
-87,800
| -14% | -$5.06M | 0.01% | 1284 |
|
|
2015
Q3 | $34.1M | Buy |
626,700
+26,300
| +4% | +$1.71M | 0.01% | 1217 |
|
|
2015
Q2 | $40.3M | Buy |
600,400
+114,100
| +23% | +$7.45M | 0.01% | 964 |
|
|
2015
Q1 | $28.5M | Sell |
486,300
-159,600
| -25% | -$9.64M | 0.01% | 1124 |
|
|
2014
Q4 | $42.3M | Sell |
645,900
-389,100
| -38% | -$24.5M | 0.02% | 933 |
|
|
2014
Q3 | $59.8M | Buy |
1,035,000
+841,000
| +434% | +$46.7M | 0.02% | 750 |
|
|
2014
Q2 | $10.9M | Buy |
194,000
+65,400
| +51% | +$3.43M | ﹤0.01% | 1850 |
|
|
2014
Q1 | $6.61M | Sell |
128,600
-144,700
| -53% | -$7.31M | ﹤0.01% | 2156 |
|
|
2013
Q4 | $14.4M | Buy |
273,300
+114,600
| +72% | +$5.63M | 0.01% | 1550 |
|
|
2013
Q3 | $7.1M | Buy |
158,700
+97,200
| +158% | +$4.31M | ﹤0.01% | 2093 |
|
|
2013
Q2 | $2.54M | Buy |
+61,500
| New | +$2.69M | ﹤0.01% | 2939 |
|
Other funds holding ABBV
VCM
VPM
Bank of America's ABBV Position: Q1 2026 in Review
Bank of America reduced its AbbVie (ABBV) stake by 7.3% in Q1 2026, selling an estimated $419M and leaving 23,936,943 shares worth $5.21B. The position accounts for 0.38% of the portfolio, ranked #48.
Bank of America first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.9B in Q4 2025. 4,090 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Bank of America held 23,936,943 shares of AbbVie worth $5.21B as of Q1 2026.
- Bank of America sold 1,887,456 AbbVie shares in Q1 2026, an estimated $419M.
- AbbVie made up 0.38% of Bank of America's portfolio in Q1 2026, its #48 holding.
- Bank of America first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Bank of America's AbbVie position peaked at $5.9B in Q4 2025.
- 4,090 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.